#4 - DocuSign (NASDAQ:DOCU)
DocuSign (DOCU) One of the best ways to reduce risk of exposure to the coronavirus is to minimize human contact. E-signature technology has existed for several years and DocuSign is the industry’s best-known name. DocuSign (NASDAQ:DOCU) is an application that allows individuals to authenticate documents with their electronic signature over the internet. There’s no need to meet in person, no exchanging papers or shaking hands afterwards. It’s all done electronically.
And DocuSign is not just a virus-inspired play. One of the big contradictions of the social media generation is how much they look to avoid human contact. If they can do something without having to have human interaction, they will. As a parent of three children ranging from 13 to 21, I see this behavior every day. I’m not sure what that says about our society, but I know what it says about DocuSign.
DocuSign saw sales grow by 14% in the last quarter. That would not be factoring in the arrival of the coronavirus. And though not profitable by GAAP accounting standards, the company is generating positive free cash flow. The company booked more than $50 million in cash profits over the past 12 months. And analysts project the company’s profitability may grow in excess of 58% annually over the next five years.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More - Current Price
- $83.03
- Consensus Rating
- Hold
- Ratings Breakdown
- 2 Buy Ratings, 7 Hold Ratings, 2 Sell Ratings.
- Consensus Price Target
- $65.80 (20.8% Downside)
